Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.

Show other versions (1)

BACKGROUND AND PURPOSE: Tumour hypoxia is associated with a poor prognosis in head and neck squamous cell carcinoma (HNSCC), however there is no accepted method for assessing hypoxia clinically. We aimed to conduct a technical validation of a hypoxia gene expression signature using the TaqMan Low De...

Full description

Bibliographic Details
Main Authors:	Betts, G, Eustace, A, Patiar, S, Valentine, H, Irlam, J, Ramachandran, A, Merve, A, Homer, J, Möller-Levet, C, Buffa, F, Hall, G, Miller, C, Harris, A, West, C
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
by: Betts, G, et al.
Published: (2013)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis
by: Moller-Levet, C, et al.
Published: (2009)

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.
by: Thurlow, J, et al.
Published: (2010)

The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
by: Lander, Eric Steven
Published: (2013)

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
by: Gee, H, et al.
Published: (2010)

A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
by: Vachani, A, et al.
Published: (2007)

The relevance of adhesion molecules in the classification of squamous cell carcinoma of the head and neck.
by: Lieder, A, et al.
Published: (2005)

Gene expression profiling to distinguish head and neck squamous cell carcinoma metastases from primary lung squamous cell carcinoma
by: Singhal, S, et al.
Published: (2004)

Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
by: Beasley, N, et al.
Published: (2001)

Feasibility of multiparametric imaging with PET/MR in head and neck squamous cell carcinoma
by: Rasmussen, J, et al.
Published: (2016)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.
by: Wigfield, S, et al.
Published: (2008)

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
by: Winter, S, et al.
Published: (2007)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
by: Winter, S, et al.
Published: (2009)

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
by: Maula, S, et al.
Published: (2003)

Effects of the novel polyphenol conjugate DPP-23 on head and neck squamous cell carcinoma cells in vitro
by: Taeger, J, et al.
Published: (2018)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
by: Ramachandran, A, et al.
Published: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
by: Ramachandran, A, et al.
Published: (2013)

Investigating the role of ADAM10 and ADAM17 in cetuximab resistance in head and neck squamous cell carcinoma
by: Kareemaghay, S
Published: (2014)

Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
by: Buffa, F, et al.
Published: (2004)

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2002)

Inhibition of CD4/CDK6 enhances radiosensitivity of HPV negative head and neck squamous cell carcinomas
by: Göttgens, E, et al.
Published: (2019)

The role of non‐oropharyngeal biopsies in head and neck squamous cell carcinoma of unknown primary: A systematic review
by: Bowe, CM, et al.
Published: (2024)

Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
by: Gasparini, G, et al.
Published: (1995)

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
by: Evans, S, et al.
Published: (2000)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
by: Eustace, A, et al.
Published: (2013)

Treatment Outcome for Head and Neck Squamous Cell Carcinoma in a Developing Country: University Malaya Medical Centre, Malaysia from 2003-2010
by: Wong, Y.F., et al.
Published: (2015)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
by: Okonjo, FA, et al.
Published: (2009)

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
by: Balermpas, P, et al.
Published: (2014)

Silencing endogenous mutant P53 Using Sirna Induces P73-Mediated Apoptosis in Human Head And Neck Squamous Cell Carcinoma
by: Arief Ichwan, Solachuddin Jauhari, et al.
Published: (2011)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
by: Irlam-Jones, J, et al.
Published: (2016)

Efficacy of Afatinib in the treatment of patients with non-small cell lung cancer and head and neck squamous cell carcinoma: a systematic review and meta-analysis
by: Maarof, Nian N. N., et al.
Published: (2021)

The management of head-and-neck paragangliomas.
by: Capatina, C, et al.
Published: (2013)

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy
by: Koukourakis, MI, et al.
Published: (2009)

The epidemiology of conjunctival squamous cell carcinoma in Uganda.
by: Newton, R, et al.
Published: (2002)

IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer
by: Dale, OT, et al.
Published: (2015)

Usefulness of nuclear morphometry and agNOR score in predicting radiation response in squamous cell cancer of the head and neck
by: Biswal, Biswa Mohan, et al.
Published: (2000)

Lymphangiogenesis in melanoma, squamous cell carcinoma and breast carcinoma
by: Skobe, M, et al.
Published: (2001)

A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients
by: Yang, L, et al.
Published: (2017)

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2004)

Correspondence re: S. Maula et al., intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. Cancer Res., 63: 1920-1926, 2003.
by: Padera, T, et al.
Published: (2003)